Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05706064
NCT05706064
Completed
Not Applicable

Survey of COVID-19 Infection

Xijing Hospital1 site in 1 country200,000 target enrollmentDecember 28, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID-19Infections

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Xijing Hospital
Enrollment
200000
Locations
1
Primary Endpoint
All-cause mortality
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Registry
clinicaltrials.gov
Start Date
December 28, 2022
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Xijing Hospital
Responsible Party
Principal Investigator
Principal Investigator

LingTao

Professor in Cardiology, Director of the department of Cardiology

Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: 6 months

Quickly obtain the all-cause mortality in patients with COVID-19

Secondary Outcomes

  • Hospitalization rate due to COVID-19 infection(6 months)
  • Medication for COVID-19 treatment(6 months)
  • Severity of COVID-19 infection(6 months)
  • Incidence rate of COVID-19 infection(6 months)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Clinical Course and Treatment of COVID-19 Inpatients in HospitalCOVID-19
NCT04527497Wissenschaftliches Institut Bethanien e.V35
Active, not recruiting
Not Applicable
COVID-19 and Cancer Consortium RegistryCOVID-19Invasive Malignancy (Any Type)
NCT04354701Vanderbilt-Ingram Cancer Center19,275
Recruiting
Not Applicable
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology EfficacyCovid19
NCT04678193Aventyn, Inc.27,000
Completed
Not Applicable
COVID-19 Active Research Experience (CARE)COVID-19
NCT04368065Iqvia Pty Ltd35,278
Completed
Not Applicable
Incidence of Infection and Mortality by COVID-19 in SpecialistsCovid19Health Care Associated InfectionInfection, CoronavirusDeath
NCT04828148Instituto Mexicano del Seguro Social400